Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during α-interferon treatment
- 1 March 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 30 (3), 366-375
- https://doi.org/10.1016/s0168-8278(99)80092-0
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Non-organ specific autoantibodies in children with chronic hepatitis CJournal of Hepatology, 1996
- Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infectionClinical and Experimental Immunology, 1994
- Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and Western blot and their association with anti-HCV and HCV-RNAClinical and Experimental Immunology, 1993
- Immunologic and viral markers in the circulation of anti‐HIV negative heroin addictsEuropean Journal of Clinical Investigation, 1993
- LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.Journal of Clinical Investigation, 1991
- Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneityThe Lancet, 1991
- Anti-liver kidney microsome antibody type 1 recognizes human cytochrome P450 db1Biochemical and Biophysical Research Communications, 1989
- Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.Journal of Clinical Investigation, 1989
- Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.Proceedings of the National Academy of Sciences, 1988
- Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitisHepatology, 1987